22-50582319-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_005198.5(CHKB):c.263C>T(p.Pro88Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000233 in 1,583,094 control chromosomes in the GnomAD database, including 1 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00025 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00023 ( 1 hom. )
Consequence
CHKB
NM_005198.5 missense
NM_005198.5 missense
Scores
6
8
5
Clinical Significance
Conservation
PhyloP100: 7.58
Genes affected
CHKB (HGNC:1938): (choline kinase beta) Choline kinase (CK) and ethanolamine kinase (EK) catalyze the phosphorylation of choline/ethanolamine to phosphocholine/phosphoethanolamine. This is the first enzyme in the biosynthesis of phosphatidylcholine/phosphatidylethanolamine in all animal cells. The highly purified CKs from mammalian sources and their recombinant gene products have been shown to have EK activity also, indicating that both activities reside on the same protein. The choline kinase-like protein encoded by CHKL belongs to the choline/ethanolamine kinase family; however, its exact function is not known. Read-through transcripts are expressed from this locus that include exons from the downstream CPT1B locus. [provided by RefSeq, Jun 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHKB | NM_005198.5 | c.263C>T | p.Pro88Leu | missense_variant | 2/11 | ENST00000406938.3 | NP_005189.2 | |
CHKB-CPT1B | NR_027928.2 | n.481C>T | non_coding_transcript_exon_variant | 2/30 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHKB | ENST00000406938.3 | c.263C>T | p.Pro88Leu | missense_variant | 2/11 | 1 | NM_005198.5 | ENSP00000384400.3 |
Frequencies
GnomAD3 genomes AF: 0.000250 AC: 38AN: 152148Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
38
AN:
152148
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000296 AC: 58AN: 196110Hom.: 0 AF XY: 0.000394 AC XY: 42AN XY: 106466
GnomAD3 exomes
AF:
AC:
58
AN:
196110
Hom.:
AF XY:
AC XY:
42
AN XY:
106466
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000231 AC: 331AN: 1430946Hom.: 1 Cov.: 32 AF XY: 0.000258 AC XY: 183AN XY: 709234
GnomAD4 exome
AF:
AC:
331
AN:
1430946
Hom.:
Cov.:
32
AF XY:
AC XY:
183
AN XY:
709234
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000250 AC: 38AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.000256 AC XY: 19AN XY: 74322
GnomAD4 genome
AF:
AC:
38
AN:
152148
Hom.:
Cov.:
33
AF XY:
AC XY:
19
AN XY:
74322
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
24
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Apr 18, 2024 | Variant summary: CHKB c.263C>T (p.Pro88Leu) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.0003 in 196110 control chromosomes. c.263C>T has been reported in the literature in two siblings with Proximal Myopathy (Brady_2016). These report(s) do not provide unequivocal conclusions about association of the variant with Megaconial Type Congenital Muscular Dystrophy. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 26782016). ClinVar contains an entry for this variant (Variation ID: 447030). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Athena Diagnostics | Jun 07, 2016 | - - |
Megaconial type congenital muscular dystrophy Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 10, 2019 | The CHKB c.263C>T (p.Pro88Leu) variant is a missense variant that has been reported in one study where it was identified in a compound heterozygous state with a second missense variant in two siblings who were diagnosed with proximal myopathy with focal depletion of mitochondria (Brady et al. 2016). The distinctive "oligomitochondrial" pattern with enlarged mitochondria around the periphery was observed in muscle biopsies from both patients. Control data are unavailable for this variant, which is reported at a frequency of 0.003146 in the Ashkenazi Jewish population of the Genome Aggregation Database. Based on the limited evidence available, the p.Pro88Leu variant is classified as a variant of unknown significance but suspicious for pathogenicity for CHKB-related congenital muscular dystrophy. This variant was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 20, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Pathogenic
D
PROVEAN
Pathogenic
D
REVEL
Uncertain
Sift
Benign
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MVP
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at